Know Labs (NYSEAMERICAN:KNW) Trading Up 3.8% – Here’s What Happened

Know Labs, Inc. (NYSEAMERICAN:KNW) shares traded up 3.8% on Wednesday . The company traded as high as $2.17 and last traded at $2.1390. 612,050 shares traded hands during trading, an increase of 60% from the average session volume of 381,756 shares. The stock had previously closed at $2.06.

Know Labs Stock Up 3.8%

The company’s fifty day moving average is $2.14 and its two-hundred day moving average is $2.14. The firm has a market capitalization of $16.04 million, a price-to-earnings ratio of -0.33 and a beta of 1.83.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Cerity Partners LLC acquired a new stake in shares of Know Labs during the second quarter worth $158,000. Corient Private Wealth LLC acquired a new position in Know Labs in the second quarter valued at about $99,000. Finally, Bard Financial Services Inc. acquired a new position in Know Labs in the third quarter valued at about $80,000. Institutional investors and hedge funds own 23.96% of the company’s stock.

About Know Labs

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.